Endoproteinase activity of type A botulinum neurotoxin: Substrate requirements and activation by serum albumin

被引:108
作者
Schmidt, JJ
Bostian, KA
机构
[1] Toxinology Division, U.S. Army Medical Research Institute of Infectious Diseases, Frederick
来源
JOURNAL OF PROTEIN CHEMISTRY | 1997年 / 16卷 / 01期
关键词
botulinum neurotoxin; peptide proteolysis; metalloproteinases;
D O I
10.1023/A:1026386710428
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Type A botulinum neurotoxin, a zinc-dependent endoproteinase that selectively cleaves the neuronal protein SNAP-25, can also cleave relatively short peptides. We found that bovine and other serum albumins stimulated the type A-catalyzed hydrolysis of synthetic peptide substrates, through a direct effect on the kinetic constants of the reaction. Furthermore, with bovine serum albumin in the assays, the optimum substrate size was 16 residues (11 on the amino-terminal side of the cleavage site and 5 on the carboxy-terminal side). To further investigate the catalytic requirements of the neurotoxin, peptides were synthesized with various amino acid substitutions at the P5 through P5' substrate sites. Changes at all of these locations affected values for both k(cat) and K-m. Substitutions at the P2, P1', and P2' sites had more pronounced effects on hydrolysis rates than did substitutions at the P1 site. Enzyme-substrate interactions at the P3' threonine probably involved the side-chain methyl group rather than the hydroxyl group. Replacing the P2' alanine with leucine eliminated detectable hydrolysis, but not binding, since this peptide was an inhibitor. A negatively charged residue was preferred at P5, but not at P4. The data indicate that type A botulinum neurotoxin has an extended substrate recognition region and a requirement for arginine as the P1' residue.
引用
收藏
页码:19 / 26
页数:8
相关论文
共 28 条
[1]   Tetanus toxin inhibits neuroexocytosis even when its Zn2+-dependent protease activity is removed [J].
Ashton, AC ;
Li, Y ;
Doussau, F ;
Weller, U ;
Dougan, G ;
Poulain, B ;
Dolly, JO .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (52) :31386-31390
[2]   BOTULINUM NEUROTOXIN-A SELECTIVELY CLEAVES THE SYNAPTIC PROTEIN SNAP-25 [J].
BLASI, J ;
CHAPMAN, ER ;
LINK, E ;
BINZ, T ;
YAMASAKI, S ;
DECAMILLI, P ;
SUDHOF, TC ;
NIEMANN, H ;
JAHN, R .
NATURE, 1993, 365 (6442) :160-163
[3]   SOLID-PHASE SYNTHESIS, CONFORMATIONAL-ANALYSIS AND IN-VITRO CLEAVAGE OF SYNTHETIC HUMAN SYNAPTOBREVIN-II-1-93 BY TETANUS TOXIN-L CHAIN [J].
CORNILLE, F ;
GOUDREAU, N ;
FICHEUX, D ;
NIEMANN, H ;
ROQUES, BP .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1994, 222 (01) :173-181
[4]  
DOLLY JO, 1992, HDB EXPT PHARM SELEC, V102, P681
[5]   TETANUS TOXIN - PRIMARY STRUCTURE, EXPRESSION IN ESCHERICHIA-COLI, AND HOMOLOGY WITH BOTULINUM TOXINS [J].
EISEL, U ;
JARAUSCH, W ;
GORETZKI, K ;
HENSCHEN, A ;
ENGELS, J ;
WELLER, U ;
HUDEL, M ;
HABERMANN, E ;
NIEMANN, H .
EMBO JOURNAL, 1986, 5 (10) :2495-2502
[6]   EVIDENCE THAT TRANSGLUTAMINASE AND SYNAPSIN-I ARE INVOLVED IN THE NEUROPARALYTIC ACTION OF TETANUS TOXIN [J].
FACCHIANO, F ;
DITULLIO, M ;
LUINI, A .
TOXINS AND EXOCYTOSIS, 1994, 710 :107-119
[7]   Botulinum neurotoxin C1 cleaves both syntaxin and SNAP-25 in intact and permeabilized chromaffin cells: Correlation with its blockade of catecholamine release [J].
Foran, P ;
Lawrence, GW ;
Shone, CC ;
Foster, KA ;
Dolly, JO .
BIOCHEMISTRY, 1996, 35 (08) :2630-2636
[8]   DIFFERENCES IN THE PROTEASE ACTIVITIES OF TETANUS AND BOTULINUM-B TOXINS REVEALED BY THE CLEAVAGE OF VESICLE-ASSOCIATED MEMBRANE-PROTEIN AND VARIOUS SIZED FRAGMENTS [J].
FORAN, P ;
SHONE, CC ;
DOLLY, JO .
BIOCHEMISTRY, 1994, 33 (51) :15365-15374
[9]   THERAPEUTIC USES OF BOTULINUM TOXIN [J].
JANKOVIC, J ;
BRIN, MF .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (17) :1186-1194
[10]   A UNIQUE SIGNATURE IDENTIFIES A FAMILY OF ZINC-DEPENDENT METALLOPEPTIDASES [J].
JONGENEEL, CV ;
BOUVIER, J ;
BAIROCH, A .
FEBS LETTERS, 1989, 242 (02) :211-214